Minor
TIGeR-PaC · Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Enrollment closed, study ongoing
Also in this update: Trial sites reduced: 42 → 31 locations
RenovoRxPhase 3 NCT03257033 Registry history of NCT03257033 on ClinicalTrials.gov (opens the registry)